Search | Charles Explorer

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical Trial

2023 | Central Library of Charles University, Third Faculty of Medicine